From January 1, 2022 to March 31, 2022, the company has repurchased 2,577,770 shares, representing 2.17% for $350.01 million. With this, the company has completed the repurchase of 83,772,784 shares, representing 57.74% for $7,157.56 million under the buyback announced on October 20, 2010.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,651 GBX | +0.70% | +2.51% | +13.85% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 22 | European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.85% | 82.63B | |
+27.92% | 659B | |
+27.68% | 557B | |
-4.59% | 359B | |
+16.38% | 322B | |
+9.39% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.58% | 149B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.